BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36770640)

  • 21. Advances in NAD-Lowering Agents for Cancer Treatment.
    Ghanem MS; Monacelli F; Nencioni A
    Nutrients; 2021 May; 13(5):. PubMed ID: 34068917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells.
    Tan B; Dong S; Shepard RL; Kays L; Roth KD; Geeganage S; Kuo MS; Zhao G
    J Biol Chem; 2015 Jun; 290(25):15812-15824. PubMed ID: 25944913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling.
    Chowdhry S; Zanca C; Rajkumar U; Koga T; Diao Y; Raviram R; Liu F; Turner K; Yang H; Brunk E; Bi J; Furnari F; Bafna V; Ren B; Mischel PS
    Nature; 2019 May; 569(7757):570-575. PubMed ID: 31019297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation.
    Kraus D; Reckenbeil J; Veit N; Kuerpig S; Meisenheimer M; Beier I; Stark H; Winter J; Probstmeier R
    Cell Oncol (Dordr); 2018 Oct; 41(5):485-494. PubMed ID: 29949049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A fluorometric assay for high-throughput screening targeting nicotinamide phosphoribosyltransferase.
    Zhang RY; Qin Y; Lv XQ; Wang P; Xu TY; Zhang L; Miao CY
    Anal Biochem; 2011 May; 412(1):18-25. PubMed ID: 21211508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinal toxicity, in vivo and in vitro, associated with inhibition of nicotinamide phosphoribosyltransferase.
    Zabka TS; Singh J; Dhawan P; Liederer BM; Oeh J; Kauss MA; Xiao Y; Zak M; Lin T; McCray B; La N; Nguyen T; Beyer J; Farman C; Uppal H; Dragovich PS; O'Brien T; Sampath D; Misner DL
    Toxicol Sci; 2015 Mar; 144(1):163-72. PubMed ID: 25505128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel assay for simultaneous measurement of pyridine mononucleotides synthesizing activities allows dissection of the NAD(+) biosynthetic machinery in mammalian cells.
    Zamporlini F; Ruggieri S; Mazzola F; Amici A; Orsomando G; Raffaelli N
    FEBS J; 2014 Nov; 281(22):5104-19. PubMed ID: 25223558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells.
    Grozio A; Sociali G; Sturla L; Caffa I; Soncini D; Salis A; Raffaelli N; De Flora A; Nencioni A; Bruzzone S
    J Biol Chem; 2013 Sep; 288(36):25938-25949. PubMed ID: 23880765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and Degradation of Adenosine 5'-Tetraphosphate by Nicotinamide and Nicotinate Phosphoribosyltransferases.
    Amici A; Grolla AA; Del Grosso E; Bellini R; Bianchi M; Travelli C; Garavaglia S; Sorci L; Raffaelli N; Ruggieri S; Genazzani AA; Orsomando G
    Cell Chem Biol; 2017 May; 24(5):553-564.e4. PubMed ID: 28416276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model.
    Sociali G; Raffaghello L; Magnone M; Zamporlini F; Emionite L; Sturla L; Bianchi G; Vigliarolo T; Nahimana A; Nencioni A; Raffaelli N; Bruzzone S
    Oncotarget; 2016 Jan; 7(3):2968-84. PubMed ID: 26658104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinoma.
    Nomura M; Ohuchi M; Sakamoto Y; Kudo K; Yaku K; Soga T; Sugiura Y; Morita M; Hayashi K; Miyahara S; Sato T; Yamashita Y; Ito S; Kikuchi N; Sato I; Saito R; Yaegashi N; Fukuhara T; Yamada H; Shima H; Nakayama KI; Hirao A; Kawasaki K; Arai Y; Akamatsu S; Tanuma SI; Sato T; Nakagawa T; Tanuma N
    Nat Commun; 2023 Dec; 14(1):8095. PubMed ID: 38092728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-613 Promotes Cell Death in Breast Cancer Cells by Downregulation of Nicotinamide Phosphoribosyltransferase and Reduction of NAD.
    Alizadeh-Fanalou S; Hosseinkhani S; Nazarizadeh A; Ezzati-Mobaser S; Hesari Z; Aziminezhadan P; Abdolvahabi Z; Abolmaali M; Tavakoli-Yaraki M; Nourbakhsh M
    DNA Cell Biol; 2021 Jul; 40(7):1026-1036. PubMed ID: 34101492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Nampt inhibitor FK866 mimics vitamin B3 deficiency by causing senescence of human fibroblastic Hs68 cells via attenuation of NAD(+)-SIRT1 signaling.
    Song TY; Yeh SL; Hu ML; Chen MY; Yang NC
    Biogerontology; 2015 Dec; 16(6):789-800. PubMed ID: 26330291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NAD- and NADPH-Contributing Enzymes as Therapeutic Targets in Cancer: An Overview.
    Pramono AA; Rather GM; Herman H; Lestari K; Bertino JR
    Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32111066
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Duarte-Pereira S; Fajarda O; Matos S; Luís Oliveira J; Silva RM
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation.
    Audrito V; Messana VG; Deaglio S
    Front Oncol; 2020; 10():358. PubMed ID: 32266141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of NAPRT1 expression by tumor-specific promoter methylation provides a novel predictive biomarker for NAMPT inhibitors.
    Shames DS; Elkins K; Walter K; Holcomb T; Du P; Mohl D; Xiao Y; Pham T; Haverty PM; Liederer B; Liang X; Yauch RL; O'Brien T; Bourgon R; Koeppen H; Belmont LD
    Clin Cancer Res; 2013 Dec; 19(24):6912-23. PubMed ID: 24097869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular nicotinate phosphoribosyltransferase binds Toll like receptor 4 and mediates inflammation.
    Managò A; Audrito V; Mazzola F; Sorci L; Gaudino F; Gizzi K; Vitale N; Incarnato D; Minazzato G; Ianniello A; Varriale A; D'Auria S; Mengozzi G; Politano G; Oliviero S; Raffaelli N; Deaglio S
    Nat Commun; 2019 Sep; 10(1):4116. PubMed ID: 31511522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NAMPT inhibitor and metabolite protect mouse brain from cryoinjury through distinct mechanisms.
    Zhang XQ; Lu JT; Jiang WX; Lu YB; Wu M; Wei EQ; Zhang WP; Tang C
    Neuroscience; 2015 Apr; 291():230-40. PubMed ID: 25684751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcellular Characterization of Nicotinamide Adenine Dinucleotide Biosynthesis in Metastatic Melanoma by Using Organelle-Specific Biosensors.
    Gaudino F; Manfredonia I; Managò A; Audrito V; Raffaelli N; Vaisitti T; Deaglio S
    Antioxid Redox Signal; 2019 Nov; 31(15):1150-1165. PubMed ID: 31456414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.